Russian antihistamine shows promise treating Alzheimer's

A drug once approved as an antihistamine in Russia improved thinking processes and ability to function in patients with Alzheimer's disease in a study conducted there, said an expert at Baylor College of Medicine in Houston. The findings are published in the current issue of the journal The Lancet. read more

Read the whole article on Science Blog

More from Science Blog